ENTITY
Divi's Laboratories

Divi's Laboratories (DIVI IN)

125
Analysis
Health Care • India
Divi's Laboratories Ltd. manufactures pharmaceutical products which include generic drugs and their intermediates. The Company also undertakes contract research activities for other pharmaceutical companies.
more
bullish•Bosch Ltd
•21 Jul 2026 07:33

Insider Activity: Who Bought Their Own Stock in June 2026 ?

While July is likely to be a weak month for insider buying due to the earnings season, notable transactions have been seen in companies such as...

Logo
182 Views
Share
bullish•Abbott India
•12 Jul 2021 08:26

Global Equity Strategy: Mixed Market Environment Continues As Yields Break Down

The Hang Seng, EURO STOXX 50, MSCI ACWI ex-US, and MSCI EAFE display bearish short-term inflections and 10-year yields in the US and Germany are...

Logo
360 Views
Share
bullish•Hang Seng Index
•24 May 2021 09:58

Global Equity Strategy: Value Remains Leadership But Defensives Improving

Cyclical value Sectors continue to be our favorite areas to overweight, while defensive Sectors also continue to be worth a look (i.e., Staples,...

Logo
372 Views
Share
bullish•Cross Asset Strategy
•21 Oct 2020 03:04

India:  Confidence Returns Among EM Active Managers

Global EM managers strengthen India exposure during the recent market turbulence.  Ownership increases across Energy and Consumer Discretionary,...

Logo
375 Views
Share
•20 Dec 2019 06:20

EM Breakout -- Add Exposure

The laundry list of current market conditions consistent with the profile of a bull market continues to grow, helping support our ongoing belief...

Logo
925 Views
Share
x